In addition to a characteristic set of essential genes coronaviruses contain several so-called group-specific genes. These genes differ distinctly among the three coronavirus groups and are specific for each group. While the essential genes encode replication and structural functions, hardly anything is known about the products and functions of the group-specific genes. As a first step to elucidate their significance, we deleted the group-specific genes from the group 2 mouse hepatitis virus (MHV) genome via a novel targeted recombination system based on host switching (L. Kuo, G. J.Godeke, M. J. Raamsman, P. S. Masters, and P. J. M. , J. Virol. 74, 1393-1406. Thus, we obtained recombinant viruses from which the two clusters of group-specific genes were deleted either separately or in combination in a controlled genetic background. As all recombinant deletion mutant viruses appeared to be viable, we conclude that the MHV group-specific genes are nonessential, accessory genes. Importantly, all deletion mutant viruses were attenuated when inoculated into their natural host, the mouse. Therefore, deletion of the coronavirus group-specific genes seems to provide an attractive approach to generate attenuated live coronavirus vaccines. © 2002 Elsevier Science (USA) 
INTRODUCTION
Among the variety of proteins encoded by viruses, those that are responsible for viral replication and virion structure are of primary importance. In addition to these fundamental elements, however, many viruses specify a diverse collection of proteins, the functions of which are often still unclear, but which are known or assumed to be beneficial to the virus. These proteins may either be essential-operationally defined as being required for virus replication in cell culture-or dispensable. Examples include the cytomegalovirus proteins involved in viral immune evasion through the inhibition of MHC class I mediated antigen presentation and the human immunodeficiency virus Vpu and Nef proteins, which downregulate CD4 surface expression (Emerman and Malim, 1998; Ploegh, 1998; and references therein) .
Coronaviruses constitute a family of large, positivesense RNA viruses that usually cause respiratory or intestinal infections in a number of different species, generally in a species-specific fashion. Based on antigenic and genetic criteria, they have been divided into three distinct groups. The feature that all coronaviruses have in common is a characteristic set of essential genes encoding replication and structural functions. Interspersed among these genes are clusters of groupspecific open reading frames (ORFs) that are homologous within each group but that differ profoundly among the groups (Lai and Cavanagh, 1997) .
Of the common essential genes, the predominant one (ORF 1ab) occupies about two-thirds of the genome. Located at the 5Ј end of the genome, this replicase gene encodes two large precursors, the many functional cleavage products of which are collectively responsible for RNA replication and transcription. The other common essential genes specify the four basic structural proteins N, M, E, and S. The nucleocapsid (N) protein packages the viral RNA, forming the core of the virion. This nucleocapsid core structure is surrounded by a lipid envelope in which the membrane (M) protein occurs most abundantly. Associated with the M protein are the small envelope (E) protein and the spike (S) protein, the latter forming the viral peplomers that are involved in virus-cell and cell-cell fusion. The genes for these structural proteins invariably occur in the order 5Ј-S-E-M-N-3Ј and are located in the 3Ј third of the viral genome (Lai and Cavanagh, 1997) .
In contrast, the identities and the locations of the group-specific genes vary, and their functions have not yet been established (for reviews see Brown and Brierly, 1995; Lai and Cavanagh, 1997; Luytjes, 1995) . The vi-ruses of group 1, with feline infectious peritonitis virus (FIPV) as probably the most complex member, have as many as three group-specific genes located between the S and E genes and as many as two additional ORFs downstream of the N gene, preceding the 3Ј-untranslated region of the genome. Group 2 viruses, to which mouse hepatitis virus (MHV) belongs, have two groupspecific genes, gene 2a and a hemagglutinin-esterase (HE) ORF between ORF 1b and the S gene. Two additional group 2-specific genes, genes 4 and 5a, reside between the S and E genes. Finally, the group 3 viruses, represented by the prototype infectious bronchitis virus (IBV), have two group-specific genes between the S and E genes as well as two between the M and N genes.
For some strains of MHV, the expression of one or more of the group-specific genes has been demonstrated (Ebner et al., 1988; Zoltick et al., 1990) . Indeed, for the best characterized group 2 specific gene product, the HE protein, hemagglutinating and acetyl-esterase enzymatic activities have been demonstrated (Brian et al., 1995) . However, in a number of strains or mutants of MHV particular group-specific genes cannot be expressed, either because of failure to transcribe the corresponding mRNA (Luytjes et al., 1988; or owing to frameshifting (Weiss et al., 1993) or partial (Schwarz et al., 1990) or complete deletion of an ORF. Thus, many of these genes would appear to be nonessential, at least under certain circumstances. However, this question has never been systematically addressed. To study the functions of the group-specific genes, mutational analyses, including their complete deletion, in a controlled genetic background would be required. The necessary tools to accomplish this have been devised only relatively recently. While for some time a method based on targeted RNA recombination, developed for MHV, was the only such system described , other reverse genetic procedures for coronaviruses are now becoming available as well. These procedures use full-length infectious cDNA clones assembled into bacterial vectors (Almazan et al., 2000) or poxviral genomes (Thiel et al., 2001) or assembled in vitro (Yount et al., 2000) .
As a first step toward elucidating the functions of the coronaviral group-specific genes, we have carried out a deletion analysis of the group 2 virus MHV, strain A59. To this end we established a novel targeted RNA recombination system, which uses switching of host cell tropism as a selection principle for the construction of recombinant viruses. The key tool in this procedure is a recently constructed mutant virus, fMHV, in which the gene segment encoding the spike ectodomain was replaced by that of the FIPV S gene (Kuo et al., 2000) . This virus, which grows in feline cells, but not in murine cells, was used as the recombination partner with synthetic RNAs in which the MHV S gene was restored and in which additional intended mutations were engineered. Recom-binant viruses were subsequently selected simply on the basis of reacquisition of the ability to grow in murine cells. Our results demonstrated the efficacy of this selection system and showed that the group 2 specific genes, 2a, HE, 4, and 5a, are not essential for viability but that their deletion led to a significant attenuation of MHV in its natural host, the mouse.
RESULTS

Construction of MHV deletion mutants
To examine the role of the group-specific genes of MHV, viruses were prepared from which these genes were deleted by using targeted RNA recombination Masters et al., 1994) . The following viral deletion mutants were prepared: MHV-⌬45a, which lacks the ORFs between the S and the E gene; MHV-⌬2aHE, from which the ORFs located between the 1b and the S genes were deleted; and MHV-min, in which both these deletions were combined ( Fig. 1) . As a control an isogenic wild-type recombinant MHV-A59 (MHV-WT) was reconstructed by the same method used to create the mutants. All viruses were generated by using transcription vector pMH54 (or derivatives thereof) from which defective RNAs were synthesized and composed of the genomic 5Ј 467 nucleotides fused to the 3Ј end (approximately 8.6 kb) of the genome (Kuo et al., 2000) (Fig. 1) . For the removal of ORFs 4a, 4b, and most of 5a, a new junction was generated between the S gene and the E gene ( Fig. 1) . A small part of the 3Ј end of ORF5a, corresponding to a sequence that was preserved in a natural deletion mutant strain of MHV (MHV-S) was maintained . This sequence contains the oligopyrimidine tract suggested to be important for initiation of E gene translation (Jendrach et al., 1999) . For the deletion of ORFs 2a and HE the transcription vector was extended with the 3Ј-terminal 1200 bp of the 1b gene, and the 1b sequence was fused to the transcription regulatory sequence [TRS; located at the 5Ј end of each gene representing a signal for the synthesis of subgenomic (sg) mRNA (Lai and Cavanagh, 1997; Sawicki and Sawicki, 1998) ] that precedes the S gene ( Fig. 1 ). After generation of the transcription vectors, the deletions were recombined into the MHV genome by RNA-RNA recombination with the interspecies chimeric virus fMHV (Fig. 1, top ). In this virus the S glycoprotein ectodomain is replaced by that of FIPV, providing this virus with the ability to infect feline cells. By using fMHV as the recipient virus for recombination with donor RNAs carrying the murine S gene, recombinant viruses were easily selected on the basis of their regained natural murine cell tropism (Hsue et al., 2000; Kuo et al., 2000) .
Confirmation of the recombinant genotypes
Each recombination experiment yielded viruses that could be propagated on murine cells. The genotypes of the recombinant viruses were confirmed by reverse transcriptase (RT)-PCR performed on genomic RNA, as shown in Fig. 2 . To verify the deletion of the ORFs 4 and 5a, the RT step was performed with primer 1092, which is complementary to the 5Ј end of the M gene, while the PCR was performed with primers 1261 and 990, which are complementary to the 3Ј ends of the E and S genes, respectively. In the case of the MHV-WT recombinant, an RT-PCR product, corresponding in size with the predicted 1328 bp, was observed. As expected, a PCR product of the same length was observed for MHV-⌬2aHE. In contrast, both for MHV-⌬45a and for MHV-min much smaller RT-PCR products were detected, the decrease in size corresponding with the deletion of 736 bp. The deletion of ORFs 2a and HE was analyzed in a similar way. The RT step was performed with primer 1127, which is complementary to the 5Ј end of the S gene. The PCR was performed with primers 1173 and 1260, which are complementary to the 3Ј end of the 1b gene and the 5Ј end of the S gene, respectively. Both for MHV-WT and for MHV-⌬45a the expected PCR products (2409 bp) were detected, which were much bigger than the PCR products detected for MHV-⌬2aHE and MHV-min. The difference in size corresponded with the deletion of 2158 bp. The transcription vectors from which the defective RNAs were produced in vitro by using T7 RNA replicase are indicated on the left side. Vector pMH54 has been described before (Kuo et al., 2000) . The other vectors were derived from pMH54 as described under Materials and Methods. The arrow at the left end of each vector indicates the T7 promoter; the solid circle represents the polylinker between the 5Ј-end segment of the MHV genome (denoted 5Ј/1) and either the HE gene or the 3Ј end of the replicase gene (1b), followed by the structural and group-specific genes and the 3Ј-untranslated region and the polyadenylated segment (denoted together as 3Ј/A). Group 2 specific genes are represented by gray boxes. Positions of the sequences shown in (B) are indicated by arrowheads. On top, a scheme for targeted recombination using the interspecies chimeric virus fMHV, which only grows in feline cells, is shown. The gene encoding the hybrid S protein containing the ectodomain of the feline coronavirus S protein is indicated by a striped box in the fMHV genome. Recombinant viruses generated by the indicated cross-over event can be selected on the basis of their ability to grow in murine cells. The genomes of these viruses are represented on the right side. The 5Ј-and 3Ј-untranslated regions are denoted 5ЈUTR and 3ЈUTR, respectively. (B) Sequences in the transcription vectors indicated by the arrowheads in (A) are shown and defined as follows: 1, between the S and the 4a gene; 2, between the S and the E gene; and 3, between the 1b and the S gene. The amino acids encoded by the 3Ј ends of the S and 1b genes as well as the initiating methionine encoded by the E and S genes are indicated. The MHV TRS is boxed. The Sse8387I restriction site downstream of the S gene, created by three nucleotide mutations (bold), is underlined.
Thus, a total of 2894 nucleotides were deleted in MHVmin. Finally, the newly generated junctions, present in the genomes of the deletion mutant viruses ( Fig. 1B) , were confirmed by sequencing of the RT-PCR products (data not shown). For each virus, pairs of independently generated recombinants were plaque purified and analyzed by RT-PCR. In all cases identical results were obtained. Since the pairs of recombinant viruses grew to very similar titers and the different deletion mutant viruses also serve as independent controls for each other, subsequent experiments were performed with only one independently generated recombinant for each deletion.
RNA synthesis by MHV deletion mutants
To examine the patterns of viral RNA synthesis by the deletion mutants, infected cells were metabolically labeled with [ 33 P]orthophosphate in the presence of actinomycin D. Purified total cellular RNA was analyzed by electrophoretic separation (Fig. 3) , and radioactivity in bands of individual viral RNA species was quantitated by phosphorimager scanning (Table 1) . For the reconstructed wild-type virus (MHV-WT), the relative molar amounts of the six sg mRNA species and the genomic (g) RNA were similar to those observed previously for MHV (Hsue and Masters, 1999; Jacobs et al., 1981; Leibowitz et al., 1981; Masters et al., 1994) with one notable exception. The 4-5a/E-M-N sgRNA, which is conventionally denoted RNA4, was much more abundant than previously observed for this species in wild-type MHV (Hsue and Masters, 1999; Jacobs et al., 1981; Leibowitz et al., 1981; Masters et al., 1994) . The increased synthesis of this particular sgRNA is known to result from three nucleotide changes 13, 15, and 18 bases upstream of the consensus transcription regulatory signal, 5ЈAAUC-UAAAC3Ј, that precedes gene 4 ( Fig. 1B ) (X. Shen, L. Kuo, and P. S. Masters, unpublished results; Ontiveros et al., 2001) . The three base changes were made in the transcription vector pMH54 to create an Sse8387I DNA restriction site downstream of the S gene (Kuo et al., 2000) . The reason for the transcriptional upregulation caused by these substitutions is currently unclear.
For the deletion mutants, all variant sgRNAs had mobilities that corresponded to their predicted sizes ( Fig. 3 and Table 1) , and no prominent extra species were observed. The results of two experiments consistently indicated that the relative molar amounts of the mutant sgRNA species were quite similar to those of their wildtype counterparts, except for a few differences ( Fig. 3 and Table 1 ). First, deletion of the ORF 4/5 cluster reduced the relative molar levels of M-N and E-M-N sgRNAs as compared to their wild-type counterparts. Second, for cells infected with the ⌬2aHE mutant, the S-4-5a/E-M-N, 4-5a/E-M-N, 5a/E-M-N, and M-N sgRNAs, but not the N sgRNA, were all relatively overproduced with respect to their recombinant wild-type counterparts. The reasons for these changes are presently unknown, but they may be caused by longer range effects of overall genomic structure on the efficiency of discontinuous transcription at individual TRSs.
Analysis of viral proteins
To analyze the viruses at the protein synthesis level, cells were infected with the different recombinant vi-ruses and labeled for 3 h with 35 S-labeled amino acids. The culture media were then collected and cleared by low-speed centrifugation, while the cells were lysed. Subsequently, culture media and cell lysates were processed for immunoprecipitation with several antibodies followed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) using a 15 or 20% gel. As shown in Fig. 4A (left) , S, N, and M proteins could be precipitated from the cell lysates with the polyclonal anti-MHV serum. For the M protein the O-glycosylated M 3 species containing N-acetyl-galactosamine, galactose, and sialic acid (Krijnse Locker et al., 1992) was predominant. The radioactivity in each protein was quantitated by phosphorimager scanning of the dried gel to determine the relative amounts of the proteins present in the cells. From the results of three independent experiments, it appeared that the M/N ratio in cells infected with MHV-⌬45a or MHV-min, but not with MHV-⌬2aHE, was significantly reduced as compared to MHV-WT infected cells (Fig. 4B ). Significant changes in the S/N ratio were not observed. These results correlate with the relative reduction of M-N sgRNA in MHV-⌬45a and MHVmin infected cells (Table 1) .
Because the N protein has been found to be secreted into the culture medium of infected cells also in a nonlipid associated form (Opstelten, 1995) , the extracellular quantity of this protein is not a reliable measure of virus assembly. We therefore used the M protein for this purpose and determined the relative amount of radiolabeled protein that is secreted. As Fig. 4A (right) shows, consistently less M protein was immunoprecipitated from the culture media of MHV-⌬45a-and MHV-min-infected cells than of MHV-WT-or MHV-⌬2aHE-infected cells. Quantitation of the results of three independent experiments showed that the relative amounts of the M protein released from MHV-⌬45a-and MHV-min-infected cellsexpressed as the ratio of extracellular over cell-bound M protein (M outside/inside)-were decreased by approximately 50% (Fig. 4B ), which indicates that less viral particles were produced.
To confirm the deletion of the 2a gene in two of our mutant viruses, we analyzed the cell lysates by immunoprecipitation with a protein 2a specific antiserum (Zoltick et al., 1990) (Fig. 4C ). This antiserum is known to nonspecifically immunoprecipitate the N protein which thus served as an internal control. As expected, the 2a protein, with a predicted molecular weight of 31 kDa, was observed (to the same extent) in lysates prepared from cells infected with MHV-WT and with MHV-⌬45a but not from MHV-⌬2aHE-and MHV-min-infected cells.
Finally, the expression of the E gene was analyzed. To our initial surprise, E protein could only be detected in control cells infected with the wild-type MHV-A59 strain from the Utrecht laboratory and not in any of the recombinant virus infected cells (Fig. 4D ). Careful analysis of the sequence of the E gene in the Utrecht MHV-A59 strain revealed that it differs at two nucleotide positions from the E gene in the transcription vector pMH54 (Kuo et al., 2000) (A217G and T230C), which is based on the sequence of the Albany laboratory strain of MHV-A59. These nucleotide changes result in two amino acid substitutions (M73V and L77P). The sequence of the E gene from the Utrecht MHV-A59 is identical to that of MHV-3 (Fischer et al., 1998) . Since the anti-E serum was raised against a fusion protein based on the Utrecht MHV-A59 sequence (Raamsman et al., 2000) , we considered this difference to be the most likely explanation for the lack of E protein precipitation. Indeed, when we substituted the two nucleotides in the E gene of pMH54, the resulting recombinant virus expressed an E protein that could now be precipitated with our anti-E serum to the same extent as the E protein produced by the Utrecht MHV-A59 (data not shown).
Tissue culture growth phenotype
Next we compared the recombinant viruses for their in vitro growth characteristics. No differences were observed with respect to their cytopathic effects. They all induced extensive syncytia to the same extent as the Utrecht wild-type virus, while plaque sizes on LR7 cells were also not appreciably different. Differences were, however, observed in their one-step growth curves. Though all viruses displayed similar kinetics, MHV-⌬45a and MHV-min appeared to reach approximately 10-fold lower titers than MHV-WT and MHV-⌬2aHE ( Fig. 5) , which behaved similar to wild-type MHV-A59 (data not shown). These observations are consistent with the results of the immunoprecipitation assays which showed that, taking the appearance of the M protein as a measure, MHV-⌬45a and MHV-min were less efficiently assembled and released.
Virulence of recombinant viruses
Having analyzed their in vitro growth characteristics, the properties of the recombinant viruses were characterized in their natural host, the mouse. Thus, we determined their virulence. Mice were inoculated intracranially with 5-or 10-fold serial dilutions of MHV-WT, MHV-2aHE, MHV-45a, and MHV-min. Infected mice were observed for clinical signs and lethality. For the recombinant wild-type virus a 50% lethal dose (LD 50 ) value of 2.7 ϫ 10 4 (mean of two experiments) was calculated (Hingley et al., 1994; Reed and Muench, 1938) . This LD 50 value is five to eight times higher than the values that are usually obtained for MHV-A59 lab strains. Although the reason for this difference is not clear, it underscores the importance of taking an isogenic wild-type recombinant virus along. LD 50 values were not able to be calculated for the three deletion viruses, but must be in excess of 2.5 ϫ 10 5 , the highest concentration inoculated, as none of the mice inoculated with this dose died. Figure 6 illustrates the kinetics of mortality of mice infected with the highest dose inoculated, 2.5 ϫ 10 5 plaque forming units (PFU), of WT and deletion viruses. While all the animals inoculated with wild-type virus had died by 7 days postinfection, the deletion viruses were highly attenuated, displaying no death and less severe clinical symptoms. Despite the observation of no mortality, all mice infected with the ⌬45a and ⌬2aHE viruses showed clinical signs of hunched posture, disheveled appearance, and waddling gait during the first week postinfection; these symptoms were less severe and observed in fewer mice infected with MHV-min. Thus, all deletion viruses are attenuated relative to wild-type virus; however, the genetically minimized coronavirus seems attenuated more severely than the other deletion viruses.
DISCUSSION
One of the most distinguishing features of the coronavirus family subgroups is the nature and genomic locations of their group-specific genes. With the exception of the HE gene, essentially nothing is yet known about these genes. We now show for the group 2 coronavirus MHV, using our newly developed strategy of targeted recombination, that these group-specific genes are not essential, since recombinant viruses, from which these group-specific genes were fully deleted, could be easily recovered. While deletion of the 2a/HE gene cluster did not affect growth in vitro, deletion of the 4/5a cluster resulted in viruses that replicated to a 10-fold lesser extent. In addition, our work shows that deletion of the nonessential genes led to significant attenuation of all the viruses when inoculated into mice and therefore provides an attractive approach to generate attenuated live coronavirus vaccines.
Except for the HE protein little is known about the actual proteins encoded by the group 2 specific coronavirus genes, and this holds true as well for the groupspecific proteins of the other groups. The HE protein is a type I glycoprotein, which forms disulfide linked homodimers (Brian et al., 1995 and references therein) . Viruses that express this protein show a second, shorter fringe of peplomers on their virions. For the HE protein hemagglutinating and acetyl-esterase activities have been demonstrated, but the significance of these prop-FIG. 6. Survival of C57Bl/6 mice infected with MHV recombinants. Four-week-old mice were inoculated intracranially with various dilutions of recombinant wild-type and deletion viruses (n ϭ 5 per virus) and survival was monitored. The data for mice infected with 2.5 ϫ 10 5 PFU are shown. While the animals infected with MHV-WT had all succumbed by day 7 postinfection, all mice inoculated with the deletion mutant viruses survived until 21 days postinfection. erties remains to be established. No enzymatic activities have been assigned to the other group-specific proteins. The 31-kDa 2a protein was detected in the cytoplasm of MHV, bovine coronavirus (BCoV), and human coronavirus (HCoV)-OC43 infected cells (Bredenbeek et al., 1990a; Cox et al., 1991; Labonte et al., 1995; Zoltick et al., 1990) . The MHV and BCoV 2a proteins share 45% amino acid identity. The BCoV 2a protein was demonstrated to be a phosphoprotein (Cox et al., 1991) , but this modification could not be found for MHV (Bredenbeek et al., 1990a) . While the MHV 2a protein contains a putative nucleotide binding site (Luytjes et al., 1988) , this site is not conserved in the 2a sequence of BCoV and HCoV-OC43. Interestingly, the amino-terminal half of the coronavirus 2a protein has significant sequence identity with the carboxyl-terminal part of the torovirus 1a polyprotein (31-36%) (Snijder et al., 1991) , which is presumably involved in viral RNA synthesis. The same 2a protein domain is also homologous with the carboxyl-terminal domain of the group A rotavirus VP3 protein (20-25%), which is part of the virion core and has capping activity (Chen et al., 1999) . It cannot be excluded that these proteins have additional, common functions. Very little is known about the (putative) gene 4 and 5a products. The expression product of MHV-JHM (but not of MHV-A59) gene 4 has been demonstrated in infected cells (Ebner et al., 1988; Weiss et al., 1993) . This protein is predicted to be an integral membrane protein (Skinner and Siddell, 1985) . It has a strikingly high content of threonine residues outside the hydrophobic region. The putative ORF5a expression product has not been demonstrated in infected cells, and it has been proposed that the actual role of this region is to function as an internal ribosome entry site for the translation of the E protein. No homologies have been found for the putative products of ORFs 4 and 5a with other than group 2 coronavirus-specific sequences.
The coronaviral group-specific genes nor their protein products are required for replication at the level of the individual cell. Deletion of the 2a/HE gene cluster was without appreciable effect on in vitro viral growth, while viruses lacking the 4/5a cluster reached 10-fold lower titers. Whether this latter effect was at all due to the respective proteins not being produced is unclear. The reduced replication capacity of the ⌬4/5a viruses might simply be the consequence of the deletion per se. These viruses exhibited lower transcription efficiencies for the sgRNAs from which the M and E genes are translated. The effect thereof on the synthesis of the E protein could not be analyzed due to the lack of an appropriate antiserum. However, the reduced synthesis of the sgRNA encoding M correlates with the observed slight but significant decrease in the M protein expression level. In view of the essential role of the M and E proteins in viral assembly (Vennema et al., 1996) , this may well explain the impaired replication capacity of these viruses. A comparable result was observed for the equine arteritis virus. This arterivirus has a similar basic genome organization as MHV and also produces a 3Ј-coterminal nested set of sgRNAs. A mutation causing a twofold reduction in the amount of sgRNA3 of this virus resulted in a corresponding reduction in the amount of GP3 but in a fourfold reduction of the virus titer (Pasternak et al., 2000) . These results support the notion that corona-and related viruses (i.e., nidoviruses) have evolved to regulate, through the use of sgRNAs, the expression of their polycistronic genome, thus providing them with a mechanism to synthesize their proteins in optimal relative quantities.
In the past a number of coronaviruses have been described that carry mutations in or around one or more of their group-specific genes. While in some cases these mutations were demonstrated in viral genomes isolated directly from the animal, very often it is not clear whether they had been generated during passage of these viruses in vitro. Obviously, the generally high rate of mutation in RNA viruses and, in addition, the high frequency of homologous recombination of coronaviruses would be expected to lead to mutations that we now know not to hinder the replication capacity in cell culture. For example, an efficiently replicating MHV deletion mutant lacking a functional ns2 gene was obtained after extensive in vitro passaging of an MHV-JHM isolate (Schwarz et al., 1990) . The HE locus is highly heterogeneous among MHV strains (Luytjes, 1995; . While the gene is intact in strains JHM and S, MHV-A59 does not express its HE gene as it not only lacks the initiation codon but also a functional TRS (Luytjes et al., 1988) . A spectrum of 3Ј-truncated HE gene variants was observed in brains of mice inoculated with a MHV-JHM strain (Yokomori et al., 1993) . Similarly, considerable variation has also been found in the ORF 4 region of the group 2 coronaviruses. While a single ORF is located in MHV-JHM (Skinner and Siddell, 1985) and MHV-S , in MHV-A59 gene 4 is disrupted by a frameshift that results in two ORFs, 4a and 4b, of which only 4a is expressed (Weiss et al., 1993) . The MHV-A59 ORF4b is a shorter homolog of the MHV-JHM ORF4. In MHV-S the ORF4 is not expressed due to mutations in the TRS. The BCoV genome also contains two ORFs in this region, whereas in HCoV-OC43 a deletion has left only a small portion of the first ORF (Mounir and Talbot, 1993) . Less heterogeneity has been observed for ORF5a, although a deletion in this region has been observed in MHV-S .
Deletion of the coronavirus group-specific genes in a controlled genetic background generated viruses that were attenuated in their natural host. The genetically minimized coronavirus was attenuated more severely than the other deletion mutant viruses. These observations suggest that the functional significance of the coronavirus group-specific genes relates to their role in vi-rus-host interactions. Considering again these viruses' high frequency of mutation and recombination, these accessory genes would otherwise not have been maintained in the viral genome. However, although deletion of the MHV 2a/HE gene cluster did not affect replication in vitro, viruses lacking the 4/5a cluster replicated to a lesser extent. Therefore, while a functional role for the 2a/HE cluster in vivo seems plausible, the observed phenotypes of the viruses lacking the 4/5a cluster may well be caused by their reduced replication per se. Indeed, a recombinant MHV-JHM in which the gene 4 was genetically inactivated was not attenuated in a murine model of encephalitis (Ontiveros et al., 2001) . Consequently, as a next step to elucidate the significance of the MHV group-specific genes in vivo, these genes should be inactivated by site-specific mutagenesis.
Deletion of the coronavirus group-specific genes provides an attractive approach to generate attenuated live coronavirus vaccines. Analogous to MHV, the groupspecific genes of other coronaviruses are anticipated to be accessory genes, the deletion of which is expected to result in attenuation without strongly affecting growth in vitro. In addition, creating genetically minimized coronaviruses may generate additional space for the stable insertion of foreign genes. The recent development of various reverse genetic procedures for coronaviruses will also enable the study of the other coronavirus groupspecific genes and will finally pave the way for investigations into the pathogenesis of coronaviruses at the molecular level.
MATERIALS AND METHODS
Cells, viruses, and antibodies
MHV-A59 recombinants WT, ⌬45a, ⌬2aHE, and min were propagated in mouse LR7 cells (Kuo et al., 2000) , and plaque assays and plaque purifications were carried out with the same cells. Mouse 17 clone 1 (17Cl1) cells were used for radiolabeling of intracellular viral RNAs. Feline FCWF cells (American Type Culture Collection) were used for infection with the interspecies chimeric coronavirus virus fMHV (Kuo et al., 2000) . The rabbit polyclonal antiserum K134 to MHV-A59 (Rottier et al., 1981) , the antiserum UP3 to the 2a protein of MHV-A59 (Zoltick et al., 1990) , and the antiserum K5379 to the E protein of MHV-A59 have been described previously.
Plasmid constructs
Transcription vectors for the production of synthetic donor RNA for targeted recombination were derived from the plasmid pMH54 (Kuo et al., 2000) , which specifies a defective MHV-A59 RNA transcript consisting of the 5Ј end of the genome (467 nt) fused to codon 28 of the HE gene and running to the 3Ј end of the genome (Fig. 1) .
Plasmid pMH54 was used to construct a recombinant wild-type virus MHV-WT. Transcription vector pXH⌬45a lacks the ORFs 4a, 4b, and almost all of 5a. For the construction of this plasmid a PCR product was obtained from an MHV-A59-derived cDNA clone, pB59 (Fischer et al., 1997) , by using primer 1089 (5Ј-ACCTGCAGGACTAATCTA-AACTTTATTCTTTTTAGGGCCACGC-3Ј), which contains a PstI/Sse8387I restriction sequence and a TRS and which is complementary to the sequence just upstream of the E gene, and primer 1092 (5Ј-CCTTAAGGAATTGAACTGC-3Ј), which is complementary to the 5Ј end of the M gene. The PCR product was cloned into pGEM-T Easy (Promega) according to the manufacturer's instructions, yielding pXH0803. The PCR product was subsequently excised with PstI and EcoRV and cloned into Sse8387-I and EcoRVtreated pMH54, resulting in pXH⌬45a. Transcription vector pXH⌬2aHE lacks ORFs 2a and HE and contains approximately 1200 bp from the 3Ј end of the replicase gene fused to the S gene. To construct this plasmid a PCR product was obtained by splicing overlap extension PCR. One PCR product was obtained from another MHV-A59 cDNA clone p96 (Bredenbeek et al., 1990b) using primer 1128 (5Ј-ACGGTC-CGACTGCGCGCTTGAACACGTTG-3Ј), which contains a RsrII restriction sequence and is complementary to a region approximately 1200 bp upstream of the replicase stop codon, and primer 1130 (5Ј-CATGCAAGCTTTATTTGACATT-TACTAGGCT-3Ј), which is complementary to the 3Ј end of the replicase coding region and the TRS region that is located upstream of the S gene. The other PCR product was obtained from pMH54 using primer 1129 (5Ј-GT-CAAATAAAGCTTGCATGAGGCATAATCTAAAC-3Ј), which is complementary to primer 1130, and primer 1127 (5Ј-CCAG-TAAGCAATAATGTGG-3Ј), which is complementary to a region in the 5Ј domain of the S gene. The PCR products were purified, mixed, and used in a PCR with primers 1128 and 1127. The DNA product obtained after the second round of PCR was cloned into pGEM-T Easy, yielding pXH1802. It was excised again with RsrII and AvrII and cloned into pMH54, which had been treated with the same enzymes, resulting in pXH⌬2aHE. Transcription vector pXHmin contains the replicase 3Ј end fused to the S gene and the deletion of ORFs 4a, 4b, and 5a. This vector was constructed by cloning the fragment excised with PstI and EcoRV from pXH0803 into pXH⌬2aHE, which had been treated with Sse8387I and EcoRV. The composition of all PCR-generated segments was confirmed by DNA sequencing.
Construction of MHV mutants
Incorporation of mutations into the MHV genome by targeted RNA recombination was carried out as described previously (Hsue et al., 2000) . Donor RNAs transcribed from PacI-truncated, pMH54-derived plasmids were transfected by electroporation into feline FCWF cells that had been infected 4 h earlier with fMHV (Kuo et al., 2000) . These cells were then plated onto a monolayer of mouse LR7 cells. After 24 h of incubation at 37°C, progeny viruses released into the cell culture media were harvested and candidate recombinants were selected by two rounds of plaque purification on LR7 cells. The mutations introduced into the viral genomes were confirmed by sequencing of RT-PCR products of the relevant regions prepared by using purified genomic RNA (Fig. 2) , which were cloned into pGEM-T Easy. The primers used for the RT-PCR analysis were primer 1092, primer 990 (5Ј-CCTGATTTATCTCTC-GATTTC-3Ј), primer 1261 (5Ј-GCTGCTTACTCCTATCATAC-3Ј), primer 1127, primer 1173 (5Ј-GACTTAGTCCTCTCCT-TGA-3Ј), and primer 1260 (5Ј-CTTCAACGGTCTCAGTGC-3Ј) (Fig. 2) .
Radiolabeling of viral RNA
The metabolic labeling of virus-specific RNAs was carried out essentially as reported previously (Masters et al., 1994; Hsue and Masters, 1999) . Briefly, 17Cl1 cell monolayers were infected with each MHV recombinant at a multiplicity of 5 PFU per cell. At 2 h postinfection, cells were starved for 4 h in Eagle's MEM containing 5% dialyzed fetal bovine serum (FBS) and 1/10 of the normal phosphate concentration. Cells were then labeled for 2 h with [ 33 P]orthophosphate in phosphate-free Eagle's MEM containing 5% dialyzed FBS and 20 g actinomycin D (Sigma) per milliliter. Total cytoplasmic RNA was purified using Ultraspec reagent (Biotecx). Samples of RNA were denatured with formaldehyde and formamide, separated by electrophoresis through 1% agarose containing formaldehyde, and visualized by fluorography.
Metabolic labeling and immunoprecipitation
LR7 cells were grown and infected with each virus at a multiplicity of 8 PFU per cell. Before being labeled, cells were starved for 30 min in cysteine-and methionine-free minimal essential medium containing 10 mM HEPES (pH 7.2) and 5% dialyzed fetal bovine serum. The medium was then replaced by 600 l of the same medium containing 100 Ci in vitro cell-labeling mix (Amersham). Cells were labeled from 5 to 8 h postinfection. At the end of the labeling period, culture media were collected, cleared by low-speed centrifugation, and prepared for immunoprecipitation by the addition of 1/4 vol of 5ϫ concentrated lysis buffer (de Haan et al., 1998) . Proteins were immunoprecipitated from cell lysates as described before (de Haan et al., 1998) . Per immunoprecipitation 2.5 l of anti-MHV, 3 l of anti-E serum, and 3 l of anti-2a serum were used. Immune complexes were adsorbed to Pansorbin cells (Calbiochem) for 30 min at 4°C and were subsequently collected by centrifugation. Pellets were washed four times by resuspension and centrifugation using wash buffers as described before (de Haan et al., 1998) . The final pellets were suspended in electrophoresis sample buffer. The immunoprecipitates were heated for 2 min at 95°C and analyzed by SDS-PAGE in 15% polyacrylamide gels.
One-step growth curve
LR7 cell monolayers were grown in 35-mm dishes in DMEM supplemented with 10% FBS. Confluent monolayers were infected in parallel with each virus (8 PFU/cell) and incubated for 1 h at 37°C. After absorption, the cells were washed with PBS three times and then fed with 2 ml of DMEM-10% FBS. Viral infectivity in culture media at different times postinfection was determined by a quantal assay on LR7 cells, and 50% tissue culture infective doses (TCID 50 ) were calculated.
Animals
C57Bl/6 (B6) mice were purchased from the National Cancer Institute (Frederick, MD). Four-week-old, MHVfree male mice were used in all experiments. Mice were anesthetized with isoflurane (IsoFlo; Abbott Laboratories, North Chicago, IL). The amount of virus designated in each experiment was diluted in PBS containing 0.75% bovine serum albumin, and a total volume of 20 l was injected into the left cerebral hemisphere. Mock-infected controls were inoculated similarly.
Virulence assays
LD 50 assays were carried out as described previously (Hingley et al., 1994) . Mice were inoculated intracranially with 5-or 10-fold serial dilutions of recombinant viruses. A total of five animals per dilution per virus were analyzed. Mice were examined for signs of disease or death on a daily basis up to 21 days postinfection. LD 50 values were calculated by the Reed-Muench method (Reed and Muench, 1938) .
